Catalyst Wire Dossier Catalyst Wire Dossier

CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%

clotrimazole topical solution 1% · Allegis Holdings, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%, covering 2023-10-16 to 2023-10-16. Get the full timeline:

Most recent: FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (Allegis Holdings, LLC)

See pricing